Caroline T Nguyen1, Siba P Raychaudhuri. 1. Department of Medicine, VA Medical Center Sacramento and UC Davis School of Medicine, Division of Rheumatology, Allergy and Clinical Immunology, Hospital Way, Mather, CA 95655, USA. E-mail: sraychaudhuri@ucdavis.edu.
Sir,In response to our report on Scedosporium apiospermumsinusitis in a patient following prolonged anti-TNFα therapy,[1] Dr. Monika Matlani has brought to our notice about a case of Scedosporium prolificansosteomyelitis in an immunocompetent child. Scedosporiuminfection has been reported in both immunocompetent and immunocompromised subjects. However, Scedosporium is mostly an opportunistic fungus.In recent years, an increasing number of cases of human disease with S. apiospermum have been reported, probably due to widespread use of corticosteroids, immunosuppressants, antineoplastics and broad-spectrum antibiotics. Thus, it is essential for dermatologists to be aware of clinical presentations and diagnosis of Scedosporiuminfection.Cutaneous manifestations of Scedosporiuminfection are protean. In most cases, inoculation of spores in the cutaneous and subcutaneous tissues is due to penetrating trauma or surgery. Scedosporium spp. infections can present as papules, erythematous plaques, folliculitis, necrotic papules, cutaneous ulcers, nodules, subcutaneous abscesses, and ulcers in a sporotrichoid (lymphangitic) pattern, ecchymosis, and hemorrhagic bullae.[2-4] Thus, the cutaneous manifestations are nonspecific and can be misleading in respect to the underlying disease. In appropriate clinical scenario, specifically in immunocompromised patients, physicians need to be suspicious for Scedosporium and other opportunistic infections. On occasions, a specific diagnosis of Scedosporiuminfection may require repeated biopsies, specific fungal staining, and fungal culture.